Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience
Asthma is a chronic inflammatory condition involving the airways with varying pathophysiological mechanisms, clinical symptoms and outcomes, generally controlled by conventional therapies including inhaled corticosteroids and long-acting β 2 agonists. However, these therapies are unable to successfu...
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
SAGE Publishing
2018-10-01
|
| Edice: | Therapeutic Advances in Respiratory Disease |
| On-line přístup: | https://doi.org/10.1177/1753466618808490 |